Skip to main content
. 2021 Jun 9;12:664010. doi: 10.3389/fneur.2021.664010

Table 2.

Baseline characteristics including levels of GDF-15 in SAH cases and controls.

All Controls Cases P value
n 340 261 79
Age (year, mean ± SD) 58 ± 8 58 ± 8 58 ± 8 0.72
Men [n (%)] 90 (26) 68 (26) 22 (28) 0.75
Systolic blood pressure (mmHg, mean ± SD) 139 ± 19 138 ± 19 143 ± 18 0.020
Diastolic blood pressure (mmHg, mean ± SD) 85 ± 9.5 84 ± 9.5 87 ± 9.0 0.0090
Blood pressure medication [n (%)] 50 (15) 34 (13) 16 (20) 0.11
Body mass index (kg/m2, mean ± SD) 25.0 ± 3.8 25.0 ± 3.6 24.7 ± 4.3 0.54
Diabetes mellitus [n (%)] 8 (2.4) 5 (1.9) 3 (3.8) 0.33
Smoking [n (%)] 111 (33) 71 (27.0) 40 (51) <0.0001
High alcohol consumption* [n (%)] 12 (3.5) 11 (4.1) 1 (1.3) 0.21
Use of warfarin [n (%)] 3 (1.0) 1 (0.4) 2 (2.5) 0.074
GDF-15+ [mean ± SD (log2 transformed)] 9.61 ± 0.59 9.53 ± 0.55 9.85 ± 0.65 0.00003
GDF-15+ (median interquartile range) 739 (416) 724 (376) 942 (518) 0.0001**

GDF, growth differentiation factor 15.

*

>40 g/day for men and >30 g/day for women.

+

Normalized protein expression (NPX) values.

P-values for cases vs. controls were calculated using ANOVA or Pearson χ2.

**

Mann-Whitney U test used due to skewed distribution of GDF15 values.